ARCHIVES

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives.

March 26, 2004

Cancer Control Contract Negotiations To Start Soon; Two Weaknesses Occur In Many Proposals

March 7, 1975

ASCO Names Stratetic Planning Committee

September 23, 1988

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978

Animal Diagnostic Lab concept OK’d

February 18, 1994

NIh Clinical Center Urged To Create Governing Board

March 15, 1996